De novo variant in RING finger protein 213 causes systemic vasculopathy
JCI Insight · 2025
DOI: 10.1172/jci.insight.190094 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Ayako Kashimada und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Adenosine Triphosphatases, Moyamoya Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Systemic arterial stenosis, including moyamoya disease (MMD) and middle aortic syndrome (MAS), is a rare condition of unclear etiology. MMD is a cerebral angiopathy, and MAS affects the abdominal and thoracic aorta. Although some genetic associations with MAS have been identified, the causes remain elusive. In this study, de novo heterozygous missense variants of RING finger protein 213 ( RNF213 ) (p.His4058Pro and p.Thr4155Pro) in 2 unrelated families with MAS and MMD were studied by whole-exome sequencing. To elucidate the significance of these variants, we produced knockin mice carrying the Rnf213 p.His4058Pro variant. Homozygous knockin mice exhibited perinatal lethality because of respiratory failure and lung dysplasia, suggesting that this variant is pathogenic. Lung dysplasia in homozygous knockin mice was associated with upregulated innate immunity and inflammatory responses and downregulated cell proliferation. These findings suggested that in mice, the RNF213 p.His4058Pro variant plays critical roles in regulation of innate immunity and inflammation that affect lung development, revealing the complexity of RNF213 function in various tissues and species. In conclusion, this study provides insights into the genetic basis of MAS and MMD, highlights the potential involvement of RNF213 variants in systemic vasculopathy, and identifies unexpected associations with lung development and immune processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pediatrics, Kyorin University, Tokyo, Japan.
- Laboratory of Molecular Neuroscience and.
- Laboratory of Genome Editing for Biomedical Research, Medical Research Institute, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pathology, Institute of Science Tokyo Hospital, Tokyo, Japan.
- Center for Medical Genetics, Keio University, Tokyo, Japan.
Förderung
- JSPS KAKENHI
Zitieren
APA
Kashimada, A., Mizuno, T., Tanaka, E., Hosokawa, S., Udagawa, T., Hiraoka, Y., Uchida, K., Morio, T., Kosaki, K., & Takagi, M. (2025). De novo variant in RING finger protein 213 causes systemic vasculopathy. JCI Insight. https://doi.org/10.1172/jci.insight.190094
Vancouver
Kashimada A, Mizuno T, Tanaka E, Hosokawa S, Udagawa T, Hiraoka Y, et al. De novo variant in RING finger protein 213 causes systemic vasculopathy. JCI Insight. 2025. doi:10.1172/jci.insight.190094
BibTeX
@article{Kashimada2025,
author = {Kashimada, Ayako and Mizuno, Tomoko and Tanaka, Eriko and Hosokawa, Susumu and Udagawa, Tomohiro and Hiraoka, Yuichi and Uchida, Keisuke and Morio, Tomohiro and Kosaki, Kenjiro and Takagi, Masatoshi},
title = {De novo variant in RING finger protein 213 causes systemic vasculopathy},
journal = {JCI Insight},
year = {2025},
doi = {10.1172/jci.insight.190094}
}
EUVIMED